ENG and hereditary hemorrhagic telangiectasia: Both variants of Endoglin downregulated the chemokine receptor CCR2, and different integrin subunits, an effect which could be verified in peripheral blood macrophages from HHT-1 patients and Eng targeted, siRNA-treated HUVECs [133].